Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The discovery of first-in-class drugs: origins and evolution
Jörg Eder, Richard Sedrani, Christian Wiesmann
Nature Reviews Drug Discovery (2014) Vol. 13, Iss. 8, pp. 577-587
Closed Access | Times Cited: 467

Showing 1-25 of 467 citing articles:

A comprehensive map of molecular drug targets
Rita Santos, Oleg Ursu, Anna Gaulton, et al.
Nature Reviews Drug Discovery (2016) Vol. 16, Iss. 1, pp. 19-34
Open Access | Times Cited: 2047
Opportunities and challenges in phenotypic drug discovery: an industry perspective
John G. Moffat, Fabien Vincent, Jonathan A. Lee, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 8, pp. 531-543
Open Access | Times Cited: 813
Hit and lead criteria in drug discovery for infectious diseases of the developing world
Kei Katsuno, Jeremy N. Burrows, Ken Duncan, et al.
Nature Reviews Drug Discovery (2015) Vol. 14, Iss. 11, pp. 751-758
Closed Access | Times Cited: 516
Screening out irrelevant cell-based models of disease
Péter Horváth, Nathalie Aulner, Marc Bickle, et al.
Nature Reviews Drug Discovery (2016) Vol. 15, Iss. 11, pp. 751-769
Closed Access | Times Cited: 465
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhe Zhang, Li Zhou, Na Xie, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 429
Drug repurposing from the perspective of pharmaceutical companies
Yoonjeong Cha, T Erez, Ian J. Reynolds, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 2, pp. 168-180
Open Access | Times Cited: 365
Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results
Thomas J. Hwang, Daniel Carpenter, Julie C. Lauffenburger, et al.
JAMA Internal Medicine (2016) Vol. 176, Iss. 12, pp. 1826-1826
Open Access | Times Cited: 360
Image-based profiling for drug discovery: due for a machine-learning upgrade?
Srinivas Niranj Chandrasekaran, Hugo Ceulemans, Justin D. Boyd, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 2, pp. 145-159
Open Access | Times Cited: 320
Antibiotic Discovery: Where Have We Come from, Where Do We Go?
Bernardo Ribeiro da Cunha, Luís P. Fonseca, Cecília R. C. Calado
Antibiotics (2019) Vol. 8, Iss. 2, pp. 45-45
Open Access | Times Cited: 287
Little Fish, Big Data: Zebrafish as a Model for Cardiovascular and Metabolic Disease
Philipp Gut, Sven Reischauer, Didier Y. R. Stainier, et al.
Physiological Reviews (2017) Vol. 97, Iss. 3, pp. 889-938
Open Access | Times Cited: 282
When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis
Jack W. Scannell, Jim Bosley
PLoS ONE (2016) Vol. 11, Iss. 2, pp. e0147215-e0147215
Open Access | Times Cited: 255
High-Throughput Screening: today’s biochemical and cell-based approaches
Vincent Blay, Bhairavi Tolani, Sunita P. Ho, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 10, pp. 1807-1821
Closed Access | Times Cited: 228
Bioinformatics and Drug Discovery
Xuhua Xia
Current Topics in Medicinal Chemistry (2017) Vol. 17, Iss. 15, pp. 1709-1726
Open Access | Times Cited: 199
Toxins and drug discovery
Alan L. Harvey
Toxicon (2014) Vol. 92, pp. 193-200
Open Access | Times Cited: 194
Phenotypic drug discovery: recent successes, lessons learned and new directions
Fabien Vincent, Arsenio Nueda, Jonathan Lee, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 899-914
Open Access | Times Cited: 191
Utilizing graph machine learning within drug discovery and development
Thomas Gaudelet, Ben Day, Arian R. Jamasb, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 183
Developing predictive assays: The phenotypic screening “rule of 3”
Fabien Vincent, Paula M. Loria, Marko J. Pregel, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 293
Closed Access | Times Cited: 181
Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases
Louis Cohen, Judy H. Cho, Dirk Gevers, et al.
Gastroenterology (2019) Vol. 156, Iss. 8, pp. 2174-2189
Open Access | Times Cited: 163
Exploring different approaches to improve the success of drug discovery and development projects: a review
Geoffrey Kabue Kiriiri, Peter Njogu, Alex Mwangi
Future Journal of Pharmaceutical Sciences (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 156
AI-Based Protein Structure Prediction in Drug Discovery: Impacts and Challenges
Michael Schauperl, R. Aldrin Denny
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 13, pp. 3142-3156
Closed Access | Times Cited: 79
Is Target-Based Drug Discovery Efficient? Discovery and “Off-Target” Mechanisms of All Drugs
Arash Sadri
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 18, pp. 12651-12677
Closed Access | Times Cited: 61
Deep learning in image-based phenotypic drug discovery
Daniel Krentzel, Spencer Shorte, Christophe Zimmer
Trends in Cell Biology (2023) Vol. 33, Iss. 7, pp. 538-554
Open Access | Times Cited: 47
Discovery and development of natural product oridonin-inspired anticancer agents
Ye Ding, Chunyong Ding, Na Ye, et al.
European Journal of Medicinal Chemistry (2016) Vol. 122, pp. 102-117
Open Access | Times Cited: 156
High-Content Monitoring of Drug Effects in a 3D Spheroid Model
Frédérique Mittler, Patricia Obeïd, Anastasia V. Rulina, et al.
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 155
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs
Yinghong Li, Xiao Xu Li, Jia Jun Hong, et al.
Briefings in Bioinformatics (2018) Vol. 21, Iss. 2, pp. 649-662
Open Access | Times Cited: 154
Page 1 - Next Page

Scroll to top